Heregulin-induced epigenetic regulation of the utrophin-A promoter.

Utpal Basu, Mads Gyrd-Hansen, Santhosh M Baby, Olga Lozynska, Thomas O B Krag, Claus J Jensen, Morten Frödin, Tejvir S Khurana

    13 Citations (Scopus)

    Abstract

    Utrophin is the autosomal homolog of dystrophin, the product of the Duchenne's muscular dystrophy (DMD) locus. Utrophin is of therapeutic interest since its over-expression can compensate dystrophin's absence. Utrophin is enriched at neuromuscular junctions due to heregulin-mediated utrophin-A promoter activation. We demonstrate that heregulin activated MSK1/2 and phosphorylated histone H3 at serine 10 in cultured C2C12 muscle cells, in an ERK-dependent manner. MSK1/2 inhibition suppressed heregulin-mediated utrophin-A activation. MSK1 over-expression potentiated heregulin-mediated utrophin-A activation and chromatin remodeling at the utrophin-A promoter. These results identify MSK1/2 as key effectors modulating utrophin-A expression as well as identify novel targets for DMD therapy.
    Original languageEnglish
    JournalFEBS Letters
    Volume581
    Issue number22
    Pages (from-to)4153-8
    Number of pages5
    ISSN0014-5793
    DOIs
    Publication statusPublished - 2007

    Fingerprint

    Dive into the research topics of 'Heregulin-induced epigenetic regulation of the utrophin-A promoter.'. Together they form a unique fingerprint.

    Cite this